Curanex Pharmaceuticals Inc (CURX) News
Track canonical SquawkNews coverage tagged to CURX, Curanex Pharmaceuticals Inc. This hub brings together deduplicated headlines about alpaca us equities, markets catalysts, earnings, analyst actions, and wider market events so traders can review how a developing story changed over time. It contains 5 indexed stories across 4 publication days and is ordered by the same first-publication timeline used by LiveCast.
M
Curanex regains Nasdaq compliance after reverse stock split
Curanex Pharmaceuticals regained Nasdaq compliance after a 1-for-20 reverse stock split restored its $1.00 minimum bid price.
REGULATION | Sep 04, 2026, 08:24 PM UTC
L
CURX schedules 1-for-20 reverse stock split for Aug 20
CURX is set to execute a 1-for-20 reverse stock split on Thursday, Aug 20, according to TradeXchange Newsdesk.
REGULATION | Aug 20, 2026, 09:04 AM UTC
M
Curis plans 1-for-20 reverse stock split Thursday
Curis (CURX) is listed for a 1-for-20 reverse stock split on Thursday Aug. 20.
EQUITY | Aug 19, 2026, 08:44 PM UTC
M
Curis announces 1-for-20 reverse stock split
Curis (CURX) has a 1-for-20 reverse stock split scheduled for Thursday, Aug. 20.
EQUITY | Aug 19, 2026, 02:47 PM UTC
L
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Gainers Abivax (NASDAQ: ABVX ) shares increased by 36.0% to $130.74 during Tuesday's pre-market session. The company's market cap stands at $7.6 billion. Cuprina Holdings (Cayman) (NASDAQ: CUPR ) shares moved upwards by
EQUITY | Jun 30, 2026, 12:05 PM UTC